Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

Abstract Background The management of COVID-19 in organ transplant recipients is among the most imperative, yet less discussed, issues based on their immunocompromised status along with their vast post-transplant medication regimens. No conclusive study has been published to evaluate proper anti-vir...

Full description

Bibliographic Details
Main Authors: Mojtaba Shafiekhani, Farbod Shahabinezhad, Tahmoores Niknam, Seyed Ahmad Tara, Elham Haem, Parviz Mardani, Zahra Zare, Sedigheh Jafarian, Khatereh Mirzad Jahromi, Sara Arabsheybani, Yalda Sadat Moeini, Jalile Alavi, Seyed Soroush Jalali, Maryam Salimi, Reza Shahriarirad, Seyed Ali Malekhosseini
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Virology Journal
Subjects:
COVID-19
Coronavirus disease 2019
Transplant
Tocilizumab
Remdesivir
Online Access:https://doi.org/10.1186/s12985-021-01700-2

Internet

https://doi.org/10.1186/s12985-021-01700-2

Similar Items